Yang M, Davis TB, Pflieger L, Nebozhyn MV, et al. An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy. BMC Cancer 2022;22:256.
PMID: 35272617